Literature DB >> 21434530

Nosocomial blood stream infections in a neonatal intensive care unit in Ankara, Turkey.

Ahmet Yağmur Baş1, Nihal Demirel, Ayşegül Zenciroglu, Neşe Göl, Gönül Tanir.   

Abstract

Nosocomial blood stream infections continue to be a cause of high mortality and morbidity in newborn intensive care units (NICUs). Identification of the causative microorganisms and their antimicrobial sensitivities will guide the selection of appropriate empirical treatment. We prospectively evaluated culture-proven nosocomial sepsis cases and antibiotic sensitivity patterns seen in the NICU of Dr. Sami Ulus Children's Hospital, in Ankara, Turkey during a six-year period (2000-2006). A total of 106 nosocomial sepsis attacks were found in 100 patients, with 72 of them preterm. Gram-negative bacteria were isolated at a rate of 70.8%, gram-positive at 22.6% and Candida species (spp.) at 6.6%. The most commonly isolated microorganisms were, in order of frequency, Klebsiella spp. (39.6%), Pseudomonas aeruginosa (11.3%) and Coagulase-negative staphylococci (9.4%). During the study, 12 of the 28 term babies (42.9%) and 26 of the 72 preterm babies (36.1%) died due to nosocomial sepsis, with a mortality rate of 38%. Resistance to ampicillin was 100%, to cefotaxime 88%, to gentamicin 73%, and to amikacin 23% in gram-negative bacteria. No carbapenem resistance was found except for P. aeruginosa (25%). Resistance to penicillin was 100% and clindamycin 58.3% in gram-positive bacteria. No glycopeptide or carbapenem resistance was found. In conclusion, nosocomial sepsis still has a high mortality rate. Gram-negative bacteria were the most commonly isolated microorganisms with Klebsiella spp. being dominant. All gram-negative species were resistant to ampicillin, and all gram-positive bacteria were resistant to penicillin. No glycopeptide or carbapenem resistance was found in gram-positive bacteria. In gram-negative bacteria, low amikacin and high gentamicin and cephalosporin resistances were found. No carbapenem resistance was found except for P. aeruginosa. Restricted and alternate antibiotic usage policies seem important for the resistance problem.

Entities:  

Mesh:

Year:  2010        PMID: 21434530

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  5 in total

1.  Contemporary Trends in Global Mortality of Sepsis Among Young Infants Less Than 90 Days: A Systematic Review and Meta-Analysis.

Authors:  Ming Ying Gan; Wen Li Lee; Bei Jun Yap; Shu Ting Tammie Seethor; Rachel G Greenberg; Jen Heng Pek; Bobby Tan; Christoph Paul Vincent Hornik; Jan Hau Lee; Shu-Ling Chong
Journal:  Front Pediatr       Date:  2022-06-03       Impact factor: 3.569

2.  Candida and other yeasts of clinical importance in Aseer region, southern Saudi Arabia. Presentation of isolates from the routine laboratory setting.

Authors:  Mohamed E Hamid; Mohammed M Assiry; Martin R Joseph; Waleed O Haimour; Ihab M Abdelrahim; Fatin Al-Abed; Abdalla N Fadul; Ahmed M Al-Hakami
Journal:  Saudi Med J       Date:  2014-10       Impact factor: 1.484

Review 3.  Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis.

Authors:  Robby Markwart; Hiroki Saito; Thomas Harder; Sara Tomczyk; Alessandro Cassini; Carolin Fleischmann-Struzek; Felix Reichert; Tim Eckmanns; Benedetta Allegranzi
Journal:  Intensive Care Med       Date:  2020-06-26       Impact factor: 17.440

4.  Multiple antibiotic resistance as a risk factor for mortality and prolonged hospital stay: A cohort study among neonatal intensive care patients with hospital-acquired infections caused by gram-negative bacteria in Vietnam.

Authors:  Lynn Peters; Linus Olson; Dung T K Khu; Sofia Linnros; Ngai K Le; Håkan Hanberger; Ngoc T B Hoang; Dien M Tran; Mattias Larsson
Journal:  PLoS One       Date:  2019-05-08       Impact factor: 3.240

5.  Human umbilical-cord mesenchymal stem cells inhibit bacterial growth and alleviate antibiotic resistance in neonatal imipenem-resistant Pseudomonas aeruginosa infection.

Authors:  Zhuxiao Ren; Xuaner Zheng; Haoming Yang; Qi Zhang; Xiaohong Liu; Xiaoling Zhang; Shumei Yang; Fang Xu; Jie Yang
Journal:  Innate Immun       Date:  2019-10-18       Impact factor: 2.680

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.